To Assess the Efficacy and Safety of OTX-DED for the Short-term Treatment of Signs and Symptoms of Dry Eye Disease
Public ClinicalTrials.gov record NCT04747977. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Masked, Vehicle-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of OTX-DED (Dexamethasone Intracanalicular Ophthalmic Insert) for the Short-Term Treatment of Signs and Symptoms of Dry Eye Disease (DED)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To assess the efficacy and safety of OTX-DED for the short-term treatment of signs and symptoms of dry eye disease.
Study identification
- NCT ID
- NCT04747977
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 172 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 11, 2021
- Primary completion
- Aug 10, 2021
- Completion
- Sep 21, 2021
- Last update posted
- Feb 21, 2023
2021
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ocular Therapeutix | Inglewood | California | 90301 | — |
| Ocular Therapeutix, Inc | Mission Hills | California | 91345 | — |
| Ocular Therapeutix, Inc. | Newport Beach | California | 92663 | — |
| Ocular Therapeutix, Inc. | Santa Ana | California | 92705 | — |
| Ocular Therapeutix, Inc. | Delray Beach | Florida | 33484 | — |
| Ocular Therapeutix, Inc. | Largo | Florida | 33773 | — |
| Ocular Therapeutix | Warrenville | Illinois | 60555 | — |
| Ocular Therapeutix, Inc. | Indianapolis | Indiana | 46260 | — |
| Ocular Therapeutix | Kansas City | Missouri | 64111 | — |
| Ocular Therapeutix, Inc. | St Louis | Missouri | 63131 | — |
| Ocular Therapeutix | Poughkeepsie | New York | 12603 | — |
| Ocular Therapeutix, Inc. | Raleigh | North Carolina | 27603 | — |
| Ocular Therapeutix, Inc. | Cranberry Township | Pennsylvania | 16066 | — |
| Ocular Therapeutix, Inc. | Memphis | Tennessee | 38119 | — |
| Ocular Therapeutix, Inc. | League City | Texas | 77573 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04747977, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 21, 2023 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04747977 live on ClinicalTrials.gov.